Who is sponsoring NCT04904393?

NCT04904393 is sponsored by Monaldi Hospital.

What drugs are being tested in NCT04904393?

Interventions in NCT04904393: Implant of the device for Cardiac Contractility Modulation (CCM) Therapy.

What condition does NCT04904393 study?

NCT04904393 studies Laminopathy, Lamin A/C Gene Mutation, Heart Failure.

Is NCT04904393 still recruiting?

NCT04904393 is currently status unknown. Last updated 27 May 2021.

Last reviewed 2021-05-27 · How we verify

NCT04904393: CARDILAM-CCM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Subanalysis in Patients With CARDIoLAMinopathy Enrolled to REPORT-CCM Registry

Status unknown Last updated 27 May 2021

What this trial tests

trial testing Implant of the device for Cardiac Contractility Modulation (CCM) Therapy in Laminopathy in 20 participants. Status unknown.

Timeline

8 March 2021

Primary endpoint
31 December 2022

31 December 2023

Quick facts

Lead sponsor	Monaldi Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	20
Start date	8 March 2021
Primary completion	31 December 2022
Estimated completion	31 December 2023
Sites	1 location across Italy

Drugs / interventions tested

Implant of the device for Cardiac Contractility Modulation (CCM) Therapy

Conditions studied

Laminopathy — all drugs for Laminopathy →
Lamin A/C Gene Mutation — all drugs for Lamin A/C Gene Mutation →
Heart Failure — all drugs for Heart Failure →

Sponsor

Monaldi Hospital

Who can join

18 and older, any sex, with Laminopathy or Lamin A/C Gene Mutation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Observational, retrospective registry with acute and chronic endpoints

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Monaldi Hospital trials

Trials by the same sponsor.

NCT04902079 — Observational and Prospective Registry on Cardiac Contractility Modulation (CCM) Therapy · unknown
NCT03458065 — T-ICD vs S-ICD Shocks: Myocardial Injuries · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04904393 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Monaldi Hospital
Last refreshed: 27 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04904393.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing